Evaluation of XTR004 as a Novel 18F-labeled PET Myocardial Perfusion Imaging (MPI) Tracer in Diagnosis of Known or Suspected CAD Compared With Invasive Coronary Angiography, Fractional Flow Reserve, Index of Microcirculatory Resistance
Latest Information Update: 06 Jun 2023
At a glance
- Drugs XTR 004 (Primary) ; Adenosine
- Indications Coronary artery disease
- Focus Diagnostic use
- Sponsors Sinotau Pharmaceuticals
Most Recent Events
- 06 Jun 2023 New trial record